Le Lézard
Classified in: Health
Subject: FVT

NCPDP Taps Innovators to Examine the Future of Pharmacy and Interoperability for #NCPDP24 Opening Panel


Provocative 90-minute panel discussion will look at Pharmacists Today...5 Years from Now...10 Years from Now and Beyond at NCPDP's 2024 Annual Technology & Business Conference

SCOTTSDALE, Ariz., April 11, 2024 /PRNewswire-PRWeb/ -- NCPDP has selected six industry leaders to offer a thought-provoking look at the future of pharmacy interoperability and innovation and the evolving role of pharmacists for its Opening Keynote Panel on Tuesday, May 7th at its 2024 Annual Technology & Business Conference, Innovation Starts Here, at the Westin Kierland Resort & Spa in Scottsdale, Arizona. The opening session will be a provocative 90-minute discussion on Pharmacists Today...5 Years from Now...10 Years from Now and Beyond with perspectives from government, pharmacy, patient advocacy, industry analyst and more.

NCPDP is advancing strategic initiatives to ensure that pharmacists have the interoperability and data needed to provide clinical services as an integral part of the patient care team. - Lee Ann Stember, President & CEO, NCPDP

Panelists will look down the road at key topics including reimbursement; workforce challenges and opportunities; policy/regulation; and innovation for predictions such as: How much time will pharmacists spend dispensing five years from now? How will the clinical pharmacy model be different from the retail model? When will pharmacists be paid for clinical services? How will artificial intelligence (AI) change the role of pharmacists and their engagement with patients? Where will we be with health equity?

"NCPDP is advancing strategic initiatives to ensure that pharmacists have the interoperability and data needed to provide clinical services as an integral part of the patient care team," said Lee Ann Stember, President & CEO of NCPDP. "As the standards development organization for pharmacy, NCPDP is looking ahead at the future of pharmacy to leverage and enhance our standards to deliver solutions that enable pharmacists to operate at the top of their licensure and improve patient care."

Panelists include following esteemed industry leaders representing diverse perspectives in pharmacy related to their individual specialties:

Questions for our panel can be sent in advance of the Annual Conference to [email protected].

NCPDP's 2024 Annual Technology & Business Conference "Innovation Starts Here" is open to all healthcare industry stakeholders. To register for the conference visit https://ncpdp.org/ac/register.aspx.

The complimentary media registration form can be downloaded here.

Journalists: Click here to download photos of Joel White, Tricia Lee Rolle, Christian Tadrus, Amina Abubaker, Melissa Paige, and George Van Antwerp.

For real-time updates before and during the event, follow @NCPDP on X, NCPDP on LinkedIn, or join the discussion using NCPDP's 2024 Annual Technology & Business Conference hashtag: #NCPDP24.

About NCPDP
The National Council for Prescription Drug Programs (NCPDP) is a not-for-profit American National Standards Institute (ANSI) Accredited Standards Developer (ASD) consisting of more than 1,500 members representing entities including, but not limited to, claims processors, data management and analysis vendors, federal and state government agencies, insurers, intermediaries, pharmaceutical manufacturers, pharmacies, pharmacy benefit managers, professional services organizations, software and system vendors and other parties interested in electronic standardization within the pharmacy services sector of the healthcare industry. NCPDP provides a forum wherein our diverse membership can develop business solutions, including ANSI-accredited standards and guidance for promoting information exchanges related to medications, supplies and services within the healthcare system.

NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 80,000 pharmacies, resQtm, an industry pharmacy credentialing resource, and HCIdea®, an innovative prescriber database that provides continually updated information on more than 3.7 million prescribers. NCPDP's RxReconn® is a legislative tracking program for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs and Work Group Meetings, go online at http://www.ncpdp.org or call 480.477.1000.

Media Contact

Janet Cabibbo, NCPDP, 480-477-1000 x104, [email protected], www.NCPDP.org

Maggie Bruce, NCPDP, 480-477-1000 x144, [email protected], www.NCPDP.org

Twitter 

SOURCE NCPDP


These press releases may also interest you

at 16:36
Richards Packaging Income Fund (the "Fund") announced that the five nominees listed in the management information circular for the 2024 Annual Meeting of Unitholders were elected as Trustees of the Fund at the annual general meeting held in Toronto,...

at 16:34
An Illinois utility watchdog group has joined forces with a community that has had highly publicized problems with lead in its drinking water to file testimony arguing that Aqua Illinois' proposed $19.2 million rate hike should be slashed by at least...

at 16:30
Tarcocimab clinical and non-clinical data highlight strong 6-month efficacy profile in diabetic retinopathy patients and continued favorable safety profile.KSI-501 clinical and non-clinical data highlight multiple ascending dose safety, bioactivity...

at 16:30
Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend. For the first quarter ended March 31, 2024, revenue increased...

at 16:30
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report first quarter 2024 financial results on Wednesday, May 8, 2024. Karyopharm's management team will host a...

at 16:20
Sangamo Therapeutics, Inc. , a genomic medicine company, announced today that the company has scheduled the release of its first quarter 2024 financial results after the market closes on Thursday, May 9, 2024. The company will hold a conference...



News published on and distributed by: